Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000062

Chief Medical Officer sold 892 shares at an average $13.48 ($12,022)

  • Chief Medical Officer gave up 401 shares (to pay taxes)
  • Chief Medical Officer acquired 14,200 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-09-01 Grant or award 10b5-1 +14,200 41,330 D: show line 1 in the form
KREHER NERISSA Chief Medical Officer 2023-09-05 Shares withheld for taxes 10b5-1 −401 $14.46 $5,799 40,929 D: show line 2 in the form
KREHER NERISSA Chief Medical Officer 2023-09-06 Sale 10b5-1 −871 $13.46 $11,728 40,058 D: show line 3 in the form
KREHER NERISSA Chief Medical Officer 2023-09-06 Sale 10b5-1 −21 $14.00 $294 40,037 D: show line 4 in the form
Open-market sales · 892 sh · avg $13.48 · $12,022

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-09-01 Grant or award · Stock Option (Right to Buy) 10b5-1 +21,500 21,500 D: show line 5 in the form
Loading xslF345X05/wf-form4_169403451511634.xml…